First ‐line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison

HIV Medicine, EarlyView.

Source: HIV Medicine - May 30, 2018 Category: Infectious Diseases Authors: L Taramasso , A Di Biagio , F Maggiolo , A Tavelli , S Lo Caputo , S Bonora , M Zaccarelli , P Caramello , A Costantini , C Viscoli , A d'Arminio Monforte , A Cozzi ‐Lepri , on behalf of , M. Andreoni , G. Angarano , A. A Source Type: research